ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
April 2026
Latest News
NRC approves TerraPower construction permit
Today, the Nuclear Regulatory Commission announced that it has approved TerraPower’s construction permit application for Kemmerer Unit 1, the company’s first deployment of Natrium, its flagship sodium fast reactor.
This approval is a significant milestone on three fronts. For TerraPower, it represents another step forward in demonstrating its technology. For the Department of Energy, it reflects progress (despite delays) for the Advanced Reactor Demonstration Program (ARDP). For the NRC, it is the first approval granted to a commercial reactor in nearly a decade—and the first approval of a commercial non–light water reactor in more than 40 years.
Sakae Kinase, Shinpei Matsuhashi, Kimiaki Saito
Nuclear Technology | Volume 168 | Number 1 | October 2009 | Pages 154-157
Dose/Dose Rate | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (Part 1) / Radiation Protection | doi.org/10.13182/NT09-A9117
Articles are hosted by Taylor and Francis Online.
Knowledge of interspecies scaling of organ doses from experimental animals such as mice to humans is important in the preclinical evaluation of new radiopharmaceuticals. Interspecies scaling factors should be reliably determined since the dose-response relationships in mice would be translated to those in humans. To obtain reliable interspecies scaling factors of organ doses from mice to humans, absorbed fractions (AFs) are needed for sophisticated models on both mice and humans. In the present study, self-AFs for photons and electrons in the spleen, kidneys, and liver of both a mouse and humans were evaluated using Monte Carlo simulations. For the mouse and human models, voxel phantoms based on computed tomography were used. The sources were assumed to be monoenergetic in the energy range 10 keV to 4 MeV and to be uniformly distributed in the spleen, kidneys, and liver. Interspecies scaling factors were determined using the results of the self-AFs for the voxel mouse and voxel human. Consequently, interspecies scaling factors were found to be dependent upon energy emitted in the source organ. It was found that the scaling factor for the photon self-AF, which is corrected by the cube root of the organ mass, shows a similar trend as a function of energy with the scaling factor for the electron self-AF.